Tatva Chintan shares hit another 52-week high after turnover record
In short
Tatva Chintan shares reached another 52-week high after the company reported its highest-ever quarterly turnover. The company also said it expects the revenue trend to keep growing in the next quarters.
This matters because investors are reacting to stronger business performance and guidance. The reporting does not give the turnover number or say how much the shares moved.
What the reporting says
Tatva Chintan shares hit another 52-week high after the company reported its highest-ever quarterly turnover. The publisher summary also says Tatva Chintan Pharma expects revenue growth to keep its momentum in the next quarters, with EBITDA margin also in focus. The market reaction was positive, but the available reporting does not give the turnover figure or the exact results that drove the move.
Why it matters
Tatva Chintan shares rose to another 52-week high after the company said it posted its highest-ever quarterly turnover. The summary also points to management expecting revenue growth to continue in coming quarters, with EBITDA margin also mentioned. That supports a positive read-through for the stock, although the reporting does not provide the actual turnover amount or full financial details.